Due to the unpredictable location, fuzzy texture and diverse shape, accurate segmentation of the kidney tumor in CT images is an important yet challenging task. To this end, we in this paper present a cascaded trainable segmentation model termed as Crossbar-Net. Our method combines two novel schemes: (1) we originally proposed the crossbar patches, which consists of two orthogonal non-squared patches (i.e., the vertical patch and horizontal patch). The crossbar patches are able to capture both the global and local appearance information of the kidney tumors from both the vertical and horizontal directions simultaneously. (2) With the obtained crossbar patches, we iteratively train two sub-models (i.e., horizontal sub-model and vertical sub-model) in a cascaded training manner. During the training, the trained sub-models are encouraged to become more focus on the difficult parts of the tumor automatically (i.e., mis-segmented regions). Specifically, the vertical (horizontal) sub-model is required to help segment the mis-segmented regions for the horizontal (vertical) sub-model. Thus, the two sub-models could complement each other to achieve the self-improvement until convergence. In the experiment, we evaluate our method on a real CT kidney tumor dataset which is collected from 94 different patients including 3,500 CT slices. Compared with the state-of-the-art segmentation methods, the results demonstrate the superior performance of our method on the Dice similarity coefficient, true positive fraction, centroid distance and Hausdorff distance. Moreover, to exploit the generalization to other segmentation tasks, we also extend our Crossbar-Net to two related segmentation tasks: (1) cardiac segmentation in MR images and (2) breast mass segmentation in X-ray images, showing the promising results for these two tasks. Our implementation is released at https: //github.com/Qianyu1226/Crossbar-Net.

Background: Renal clear cell carcinoma (ccRCC) is one of the most common malignant tumors, whose incidence is increasing year by year. IRF6 plays an important role in the occurrence of tumors, although there is yet no report on its expression in ccRCC. Methods: The expression of IRF6 and KIF20A in ccRCC was predicted by GEPIA and HAP databases. In addition, GEPIA database predicted the relationship between IRF6 and KIF20A expressions and the pathological staging, overall survival, and disease-free survival of ccRCC. The possible binding sites of IRF6 and KIF20A promoters were predicted by JASPAR database and verified by luciferase and ChIP assays. The specific effects of IRF6 on ccRCC cell proliferation, invasion and apoptosis were subsequently examined at both cellular level and animal level. Results: The database predicted down-regulated IRF6 expression in renal carcinoma tissues and its correlation with poor prognosis. IRF6 overexpression inhibited cRCC cell proliferation, invasion and migration. In addition, up-regulated KIF20A expression in renal carcinoma tissues and its association with prognosis were also predicted. Interference with KIF20A inhibited the proliferation, invasion, and migration of ccRCC cells. Finally, we confirmed that KIF20A is a functional target of IRF6 and can partially reverse the effects of IRF6 on the proliferation, invasion and migration of ccRCC cells. Conclusion: Inhibition of KIF20A by transcription factor IRF6 affects cell proliferation, invasion and migration in renal clear cell carcinoma.

Background: Supervised machine learning methods [both radiomics and convolutional neural network (CNN)-based deep learning] are usually employed to develop artificial intelligence models with medical images for computer-assisted diagnosis and prognosis of diseases. A classical machine learning-based modeling workflow involves a series of interconnected components and various algorithms, but this makes it challenging, tedious, and labor intensive for radiologists and researchers to build customized models for specific clinical applications if they lack expertise in machine learning methods. Methods: We developed a user-friendly artificial intelligence-assisted diagnosis modeling software (AIMS) platform, which supplies standardized machine learning-based modeling workflows for computer-assisted diagnosis and prognosis systems with medical images. In contrast to other existing software platforms, AIMS contains both radiomics and CNN-based deep learning workflows, making it an all-in-one software platform for machine learning-based medical image analysis. The modular design of AIMS allows users to build machine learning models easily, test models comprehensively, and fairly compare the performance of different models in a specific application. The graphical user interface (GUI) enables users to process large numbers of medical images without programming or script addition. Furthermore, AIMS also provides a flexible image processing toolkit (e.g., semiautomatic segmentation, registration, morphological operations) to rapidly create lesion labels for multiphase analysis, multiregion analysis of an individual tumor (e.g., tumor mass and peritumor), and multimodality analysis. Results: The functionality and efficiency of AIMS were demonstrated in 3 independent experiments in radiation oncology, where multiphase, multiregion, and multimodality analyses were performed, respectively. For clear cell renal cell carcinoma (ccRCC) Fuhrman grading with multiphase analysis (sample size =187), the area under the curve (AUC) value of the AIMS was 0.776; for ccRCC Fuhrman grading with multiregion analysis (sample size =177), the AUC value of the AIMS was 0.848; for prostate cancer Gleason grading with multimodality analysis (sample size =206), the AUC value of the AIMS was 0.980. Conclusions: AIMS provides a user-friendly infrastructure for radiologists and researchers, lowering the barrier to building customized machine learning-based computer-assisted diagnosis models for medical image analysis.